Jonas Nilsson

21PUBLICATIONS
65CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Mar 18, 2026
Phase I trial of locoregional administration of autologous tumor-infiltrating lymphocytes in patients with uveal melanoma and liver metastases (the HAITILS trial).

Axel Nelson, Rebecca Riise, Samuel Alsén

|Feb 19, 2026
SWE-NEO: Swedish NEO-adjuvant trial comparing anti-PD-1 monotherapy to combined anti-CTLA-4/anti-PD-1 blockade in resectable stage III melanoma: study protocol for a phase III open-label multi-centre trial.

Hildur Helgadottir, Ana Carneiro, Francesca Portelli

|Nov 19, 2025
Tumour-reactive heterotypic CD8 T cell clusters from clinical samples.

Sofía Ibáñez-Molero, Johanna Veldman, Juan Simon Nieto

|Sep 30, 2025
Targeting chromatin remodeling complexes to treat uveal melanoma.

Jonas A Nilsson

|Sep 23, 2024
Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases.

Joakim W Karlsson, Vasu R Sah, Roger Olofsson Bagge

|Jun 28, 2023
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy.

Vasu R Sah, Henrik Jespersen, Joakim Karlsson

Pageof 4

Frequent Collaborators

10 joint publications

Roger Olofsson Bagge

6 joint publications

Lars Ny

4 joint publications

Joakim Karlsson

4 joint publications

Lisa M Nilsson